209 related articles for article (PubMed ID: 8480075)
1. Cellular sensitivity to native type IV collagen in primary biliary cirrhosis.
Suou T; Ago H; Sawada H; Hirayama C
Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):275-91. PubMed ID: 8480075
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte sensitivity to native human interstitial collagen in chronic liver disease.
Nishimuki E; Suou T; Kawasaki H
Res Commun Chem Pathol Pharmacol; 1993 Feb; 79(2):229-42. PubMed ID: 8451544
[TBL] [Abstract][Full Text] [Related]
3. Cellular sensitivity to collagen in liver disease.
Sawada H; Suou T; Hirayama C
Clin Exp Immunol; 1985 Feb; 59(2):364-70. PubMed ID: 2983912
[TBL] [Abstract][Full Text] [Related]
4. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum and hepatic 7S fragments of type IV collagen in chronic liver disease.
Suou T; Yamada S; Hosho K; Yoshikawa N; Kawasaki H
Hepatology; 1996 May; 23(5):1154-8. PubMed ID: 8621148
[TBL] [Abstract][Full Text] [Related]
6. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
[TBL] [Abstract][Full Text] [Related]
7. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
8. [Serum type IV collagen and laminin in patients with chronic hepatitis and its clinical significance].
Xie J; OuYang K; Su T
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):93-6. PubMed ID: 10681810
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of the serum levels of the 7S domain of type IV collagen in patients with primary biliary cirrhosis.
Fukutomi T; Sakamoto S; Isobe H; Sakai H; Masumoto A; Nawata H
J Gastroenterol Hepatol; 1992; 7(6):596-601. PubMed ID: 1486189
[TBL] [Abstract][Full Text] [Related]
10. Significance of serum type IV collagen level of hepatectomized patients with chronic liver damage.
Shimahara Y; Yamamoto N; Uyama N; Okuyama H; Momoi H; Kamikawa T; Terajima H; Iimuro Y; Yamamoto Y; Ikai I; Kushihata F; Kiyochi H; Kobayashi N; Yamaoka Y
World J Surg; 2002 Apr; 26(4):451-6. PubMed ID: 11910479
[TBL] [Abstract][Full Text] [Related]
11. [Detection of serum type IV collagen and the alteration of this collagen in various liver diseases].
Wang JG
Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):546-8. PubMed ID: 12536536
[TBL] [Abstract][Full Text] [Related]
12. Mixed types of chronic active hepatitis and primary biliary cirrhosis associated with the anti-phospholipid antibody syndrome: a case report.
Saeki R; Kaneko S; Terasaki S; Unoura M; Ogino H; Wakabayashi T; Kawara S; Nakanuma Y; Kobayashi K
Hepatogastroenterology; 1993 Oct; 40(5):499-501. PubMed ID: 8270244
[TBL] [Abstract][Full Text] [Related]
13. Impaired monocyte function in primary biliary cirrhosis.
Olmos JM; García JD; Jiménez A; de Castro S
Allergol Immunopathol (Madr); 1988; 16(5):353-8. PubMed ID: 3228054
[TBL] [Abstract][Full Text] [Related]
14. Effects of medroxyprogesterone on the liver function and drug metabolism of patients with primary biliary cirrhosis and chronic active hepatitis.
Sotaniemi EA; Hynnynen T; Ahlqvist J; Ahokas JT; Puoskari U; Pelkonen I
J Med; 1978; 9(2):117-28. PubMed ID: 276564
[TBL] [Abstract][Full Text] [Related]
15. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
Koruk M; Onuk MD; Akçay F; Savas MC
Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
[TBL] [Abstract][Full Text] [Related]
16. Evidence of an increased nitric oxide production in primary biliary cirrhosis.
Battista S; Bar F; Mengozzi G; Pollet C; Torchio M; Cavalli G; Rosina F; David E; Cutrin JC; Cavalieri B; Poli G; Molino G
Am J Gastroenterol; 2001 Mar; 96(3):869-75. PubMed ID: 11280567
[TBL] [Abstract][Full Text] [Related]
17. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
Zheng M; Cai W; Weng H; Liu R
Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis.
Dimoulios P; Kolios G; Notas G; Matrella E; Xidakis C; Koulentaki M; Tsagarakis N; Kouroumalis A; Kouroumalis E
Aliment Pharmacol Ther; 2005 Feb; 21(3):227-34. PubMed ID: 15691296
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor alpha and cellular proliferation in primary biliary cirrhosis.
Floreani A; Infantolino D; Biasin R; Della Rovere GR; Biagini MR; Melis A; Chiaramonte M
Ital J Gastroenterol Hepatol; 1999; 31(1):56-60. PubMed ID: 10091104
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of cell-matrix adhesion molecules and their ligands in the portal tracts of primary biliary cirrhosis.
Yasoshima M; Tsuneyama K; Harada K; Sasaki M; Gershwin ME; Nakanuma Y
J Pathol; 2000 Jan; 190(1):93-9. PubMed ID: 10640998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
